Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease

Author：                

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.33, Iss.4, 2014-01, pp. : 870-878

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 5, 2015-05 ,pp. : 755-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease

By Happe Svenja   Baier Paul   Helmschmied Kathrin   Meller Johannes   Tatsch Klaus   Paulus Walter  

Journal of Neurology, Vol. 254, Iss. 8, 2007-08 ,pp. : 1037-1043

Springer Publishing Company

Access to resources Recommend Favorite

Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease

By Bohnen Nicolaas   Gedela Satyanarayana   Kuwabara Hiroto   Constantine Gregory   Mathis Chester   Studenski Stephanie   Moore Robert  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease

By Ouchi Y.  

Brain, Vol. 124, Iss. 4, 2001-04 ,pp. : 784-792

Oxford University Press

Access to resources Recommend Favorite

Zonisamide reduces nigrostriatal dopaminergic neurodegeneration in a mouse genetic model of Parkinson's disease

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 134, Iss. 2, 2015-07 ,pp. : 371-381

John Wiley & Sons Inc

Access to resources Recommend Favorite